Abstract
Age has been used as a prognostic factor for patients with peripheral neuroblastic tumours (pNTs). The latest analysis disclosed a cut-off around 18 months for the optimal prognostic distinction. The International Neuroblastoma Pathology Classification (INPC) distinguishes favourable and unfavourable histology based on the age-appropriate evaluation of histologic indicators (grade of neuroblastic differentiation, mitosis-karyorrhexis index) in the categories of neuroblastoma and ganglioneuroblastoma, nodular. This study showed that age tested by using 3 different cut-offs (12, 18, 24 months) was prognostically significant. INPC remained prognostically significant regardless of the age group to which it was applied. Prognostic effects of age and histologic indicators were independently significant, i.e., age had prognostic ability beyond that of histologic indicators, and histologic indicators had prognostic ability beyond that of age. Due to the fact that INPC incorporated age factor (18, 60 months) in the system, it served better than age by itself for prognostic distinction of pNT patients.
References
Jun 1, 1987·Cancer·A E EvansH W Hann
Oct 31, 1985·The New England Journal of Medicine·R C SeegerD Hammond
Feb 1, 1971·Cancer·A E EvansJ Randolph
Jun 8, 1984·Science·G M BrodeurJ M Bishop
Oct 4, 1995·Journal of the National Cancer Institute·H ShimadaR C Seeger
Oct 16, 1999·The New England Journal of Medicine·K K MatthayC P Reynolds
Dec 18, 2001·Cancer·S GotoH Shimada
Mar 4, 2003·Nature Reviews. Cancer·Garrett M Brodeur
May 30, 2003·The Oncologist·Joanna L WeinsteinSusan L Cohn
Nov 6, 2003·Cancer·Michel PeuchmaurHiroyuki Shimada
Aug 24, 2004·Oncogene·Charles A Stiller
Sep 24, 2004·Cancer·Hiroyuki ShimadaRobert C Seeger
Nov 19, 2004·Cancer·Chie KobayashiHiroyuki Shimada
Aug 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rani E GeorgeA Thomas Look
Aug 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W B LondonS L Cohn
Aug 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary Lou SchmidtKatherine K Matthay
Citations
Oct 10, 2006·Journal of Cancer Research and Clinical Oncology·Setsuko KanekoMichio Kaneko
Jun 27, 2008·Cancer Metastasis Reviews·M Sue O'DorisioDavid Bushnell
Oct 21, 2009·Current Oncology Reports·Sabine Mueller, Katherine K Matthay
Jun 19, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C Alvarez-LasoI González-Pinto
Jan 8, 2013·Computers in Biology and Medicine·Eva VillamónRosa Noguera
Nov 13, 2012·PloS One·Gemma MayolCinzia Lavarino
Sep 17, 2011·Future Oncology·Marta JeisonShifra Ash
Jul 30, 2014·Pediatric Surgery International·Tomoro HishikiJun Iwai
Jul 3, 2015·Oncology Letters·Xiao-Xue KeHongjuan Cui
Feb 23, 2010·Current Problems in Cancer·Natia EsiashviliHoward M Katzenstein
Feb 26, 2016·Cancer Biotherapy & Radiopharmaceuticals·Liqun YangYundong Zhang
Jul 23, 2009·International Journal of Cancer. Journal International Du Cancer·Roberta VitaliGiuseppe Raschellà
Jul 22, 2014·Pediatric Blood & Cancer·Holly J MeanyJulie R Park
Mar 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel A MorgensternMeredith S Irwin
Jul 1, 2017·Pediatric Hematology and Oncology·Atif A AhmedMaxine Hetherington
Jan 10, 2008·British Journal of Cancer·M V CorriasA Garaventa
Aug 24, 2019·Medicine·Holger N LodeWinfried Barthlen
Apr 22, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth SokolWendy B London
Sep 16, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Klaus BeiskeHiroyuki Shimada
Mar 15, 2019·FEBS Open Bio·Guojin XieYong Chang
Dec 17, 2019·JCO Precision Oncology·Naohiko IkegakiUNKNOWN International Neuroblastoma Pathology Committee
Sep 9, 2017·Cancer·Wendy B LondonJulie R Park
Sep 10, 2018·BMJ Case Reports·Anders ValindDavid Gisselsson
Jul 3, 2018·Oncology Letters·Wei WuZhibao Lv
May 11, 2021·Frontiers in Immunology·Xao X TangNaohiko Ikegaki